Great analysis yourself fattchoi. And your previous post. The only missing bit for Her-vaxx is that it doesn't have FDA IND or an application for one. So am curious to see how that is dealt with given company has ann trials will include the US.
Perhaps the sponsor of the yet to be announced investigator sponsored trial will apply for IND?
This deal is truly fantastic news.
Well done and good luck Imugene.
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-63
-
- There are more pages in this discussion • 190 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.2¢ | 4.9¢ | $531.4K | 10.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 3429444 | 4.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.0¢ | 149299 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |